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HSE Update on Drug 
Market Trends
We have provided an overview of some of 
the latest trends to help you stay informed. 
High strength drugs 
Some club drugs such as cocaine and 
MDMA (pills, powders and crystals) have been 
increasing in strength throughout Europe in 
recent years. 
Higher dosed drugs can increase the risk of   
overdose (accidentally taking more than 
expected or more than your body can handle). 
There is concern that high strength drugs are
leading to increased levels of drug overdose 
and deaths among club drug users. 
European drug checking agencies have issued 
a number of alerts over the last few years 
about high strength MDMA. Ten years ago 
pills contained roughly 60 - 90 mg of MDMA, 
whereas services are now finding that pills 
can contain 2-3 times the average adult dose 
of MDMA (over 200 + mg).
New substances sold as MDMA 
The Loop UK has found increasing levels of 
new cathinone type substances and caffeine 
present across a range of pills, powders and 
crystals. 
The Loop have also identified identical pills 
containing four different substances – MDMA, 
cathinones and benzocaine. These findings 
highlight that products from the same batch 
or products that look the same can vary.  
The Loop UK recently found Metaphedrone 
(3-Methylmethcathinone, 3-MMC), 
Clephedrone  (4-Chloromethcathinone, 
4-CMC), Pentylone (N-ethylpentylone) and 
Eutylone (bk-EBDB, n-ethylbutylone ) in a 
variety of MDMA pills, powders and crystals. 
These substances are strong stimulants which 
can produce stimulation and mild euphoria 
with less empathogenic effects compared to 
MDMA. People are at risk of over consuming 
by re-dosing, mistaking the substance for weak 
MDMA. They can also produce a strong urge 
to re-dose which can lead to people over 
consuming, increasing the risks and prolonging 
he effects. These substances can cause mental 
health reactions, anxiety, hallucinations, 
prolonged stimulation and severe insomnia. 
Lack of sleep can then increase the risk of 
developing psychosis. They can also cause 
nausea, vomiting and diarrhea.
Synthetic cannabinoids in plant, 
vape and edible products 
Synthetic cannabinoids have been found in 
hash/weed, low THC products, vape/liquid 
and edible sweets in Europe and in Ireland. 
These products do not contain cannabis but are 
synthetically made to produce similar and more 
potent effects. 
These substances have been linked with 
poisonings and deaths internationally. 
You may not be able to visually tell if a product 
contains cannabis or a synthetic cannabinoid.
 
Signs of concern to look out for after 
consuming cannabis products include: 
feeling dizzy, confusion, abnormal sweating, 
respiratory issues (difficulty breathing), chest 
pain/rapid heartbeat, nausea and vomiting, 
agitation, aggression, psychotic behaviour, 
hallucinations, delusions, seizures or fits,
sudden loss of consciousness. 
HSE Update on 
New Psychoactive 
Substances Identified 
in Ireland in 2021
Through Forensic Science Ireland who analyse 
drug seizures, we are aware of the below new 
psychoactive substances appearing in Ireland 
in 2021.
These substances represent drug seizures but 
this may not provide a full overview of the 
current Irish situation and does not guarantee 
the contents of current substances in 
circulation. 
 
•  Synthetic cannabinoid, 
MDMB-4en-PINACA (29 cases): 
This substance has been found in plant 
material, liquid and vape products.
•  Synthetic cannabinoid, 
ADB-BUTINACA (10 cases): 
This substance has been found in sweets, 
plant material and liquids.
•  Synthetic cannabinoid, 
5F-EDMB-PICA (15 cases): 
This substance has been found in plant 
material and some sweets.
•  Synthetic cannabinoid, 
4F-MDMB-BUTINACA (16 cases): 
This substance has mainly been found in 
plant material and in some liquid.
•  Synthetic cathinone, 
Chloromethcathinone (5 cases): 
This substance was found in powder 
products. 
•  Synthetic cathinone, 
Fluoro-methyl-PVP (2 cases): 
This substance was found in powder 
and pill products. 
•  Ketamine analogue, 
2- Fluorodeschloroketamine (2F-DCK) 
(7 cases): This substance appeared in 
powder products and is a dissociative 
anaesthetic similar to ketamine. 
It’s safer not to use at all and there is 
a risk of unknown substances or high 
potency substances emerging. 
If you choose to use, start low and go 
slow, take a very small amount and wait 
to see how you react to the substance. 
If you take a drug and the effects are 
different to what you expected or it 
feels too strong, consider not taking 
any more and binning it. 
Don’t be afraid to get medical help 
if you or a friend become unwell after 
using drugs. 
For more information go to 
drugs.ie/Afterlockdown
#IfYouGoGoSlow
